Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|October 22, 2022
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patientsRui-Xin Deng, Xiao-Lu Zhu, Ao-Bei Zhang, et al.
Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.
Frontiers in Immunology|January 24, 2022
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionGuan-Hua Hu, Yi-Fei Cheng, Ying-Xi Zuo, et al.
American Journal of Hematology|September 29, 2023
A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Annals of Hematology|May 5, 2019
Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantationXuan Cai, Jin Wu, Ruo-Yun Gui, et al.
Cancer Letters|August 31, 2024
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Blood Advances|September 10, 2021
A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathyPeng Zhao, Ye-Jun Wu, Yun He, et al.
Cancer|August 13, 2025
Peritransplant lysine methyltransferase 2a-rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemiaLu-Lu Wang, Peng Zhao, Jing Liu, et al.
Transplantation and Cellular Therapy|January 12, 2023
A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell TransplantationAo-Bei Zhang, Chen-Cong Wang, Peng Zhao, et al.
American Journal of Hematology|July 9, 2024
Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot studyPeng Zhao, Zhuo-Yu An, Hai-Xia Fu, et al.
Pageof 18